a.sorensen
TL2 · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 28 September 2024 · last posted 1d
73 posts, newest first. Showing up to 150.
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #13 · Practice › Reconstitution · 27 Jul 2026 · 2 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. On a U-100 insulin syringe, one hundred units is one millilitre and one unit is…
-
Immortal time bias in a claims-database study — one year on Replied, post #43 · Evidence › Study critique · 25 Jul 2026 · 8 likes Defending a design that is being criticised unfairly is as useful as criticising one that deserves it, and it happens far less often. I am aware this is the third time…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #89 · Compounds › Retatrutide · 24 Jul 2026 · 24 likes Comparisons with tirzepatide are being made across trials rather than within one. Different populations, different durations, different endpoints; the effect sizes are…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #99 · Access › International · 22 Jul 2026 · 0 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging. It is the sort of thing that…
-
Documenting a supplier's response to a discrepancy Replied, post #42 · Sourcing › Vendor reports · 19 Jul 2026 · 6 likes I had written a reply contradicting post #40 and deleted it. Here is what survived. The cost of a submission is worth stating. It is the main reason people do not do…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #116 · Evidence › Journal club · 18 Jul 2026 · 17 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
What a certificate commits its issuer to Replied, post #40 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes I had written a reply contradicting post #36 and deleted it. Here is what survived. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #12 · Clinical › Comorbidities · 9 Jul 2026 · 15 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Osteoarthritis and mechanical versus metabolic, because it is the…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #10 · Access › Insurance & coverage · 8 Jul 2026 · 3 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. Small methodological point on Prior authorisation: repeating a measurement is cheap…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #76 · Evidence › Journal club · 2 Jul 2026 · 0 likes The version of SURMOUNT-OSA that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Asking a follow-up: new topic or new reply? Replied, post #10 · Start Here › How to Ask · 14 Jun 2026 · 7 likes Post #6 and I disagree about the size of the effect, not about the direction. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Injecting into an area that has become firm: why not to Replied, post #51 · Practice › Administration · 11 Jun 2026 · 0 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
-
Preservatives: function, testing, and limits — one year on Replied, post #21 · Pharmacology › Formulation chemistry · 3 Jun 2026 · 31 likes Post #20 is the version of this I will quote in future. One addition. Emulsification and suspensions: some formulations are emulsions or suspensions rather than…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #55 · Safety › Contraindications · 30 May 2026 · 19 likes Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest contraindication in this class and it is specific…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #89 · Compounds › Tirzepatide · 25 May 2026 · 31 likes The version of Tirzepatide and nausea that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #37 · Compounds › Semaglutide · 24 May 2026 · 21 likes I had written a reply contradicting post #35 and deleted it. Here is what survived. On the injection-day question: the labelling for licensed semaglutide allows the day…
-
Citation sweep results: how many references did not say what was claimed Replied, post #99 · Meta › Wiki maintenance · 21 May 2026 · 27 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #5 · Compounds › Oral incretins · 16 May 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Revisiting: What pooling buys you and what it destroys Replied, post #23 · Evidence › Meta-analyses · 15 May 2026 · 13 likes I came in to disagree and I am leaving without a disagreement.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #118 · Devices › Syringes & needles · 14 May 2026 · 16 likes Where I have landed on 0.3 ml versus 0.5 ml, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude…
-
Journal club: LEADER as the historical anchor Replied, post #70 · Evidence › Journal club · 6 May 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #16 · Data & Tools › Datasets · 30 Apr 2026 · 14 likes I read post #12 twice before replying, because I had assumed the opposite. Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #7 · Devices › Syringes & needles · 26 Mar 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Reading U-100 graduations, with a conversion table Replied, post #14 · Devices › Syringes & needles · 2 Mar 2026 · 2 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #58 · Practice › Dosing & titration · 14 Feb 2026 · 1 like A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Publication bias detection and its low power — does this still hold? Replied, post #11 · Evidence › Meta-analyses · 9 Feb 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #11 · Analytics › HPLC & UHPLC · 3 Feb 2026 · 1 like Confirming post #9 from a second method, which matters more than confirming it from a second person. Carryover from a previous injection shows up as a small peak at the…
-
When to stop reading forums, including this one Replied, post #84 · Wellbeing › Mental health · 2 Feb 2026 · 1 like Confirming post #83 from a second method, which matters more than confirming it from a second person. The social side of this — how other people respond to visible…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #125 · Compounds › Oral incretins · 2 Jan 2026 · 17 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #97 · Analytics › COA interpretation · 25 Dec 2025 · 8 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #21 · Start Here › Welcome · 16 Dec 2025 · 11 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
-
Tracking a preprint to publication: a worked example Replied, post #128 · Evidence › Preprints · 13 Dec 2025 · 8 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #116 · Practice › Reconstitution · 9 Dec 2025 · 2 likes Everything in post #112 holds. The case it does not cover is the one I have. Two questions I would want answered before drawing anything from the decimal-point error…
-
Tracking that stops updating and then resumes — the long version Replied, post #32 · Sourcing › Logistics · 31 Oct 2025 · 3 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #106 · Practice › Storage & stability · 22 Oct 2025 · 0 likes The arithmetic in post #105 is right; the assumption feeding it is the part to check. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #34 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #56 · Start Here › Welcome · 17 Oct 2025 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reconciling a supplier certificate with an independent result Replied, post #7 · Sourcing › Vendor reports · 16 Oct 2025 · 16 likes Answering the question post #3 raises rather than the one it answers. Report the certificate figure alongside the independent one. The comparison is the point and it is…
-
MHRA statements, read directly Replied, post #10 · Regional › UK & Ireland · 2 Oct 2025 · 24 likes Bookmarking this. I will come back when I have something worth adding.
-
Compounds this community declines to help with, and why Replied, post #30 · Compounds › Other compounds · 29 Sep 2025 · 23 likes Reading rather than answering, but this is the post I would point somebody at.
-
Payment method and the leverage it gives you, ranked Replied, post #25 · Sourcing › Payments · 17 Sep 2025 · 28 likes Reading back through the payment method threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #53 · Practice › Reconstitution · 3 Sep 2025 · 4 likes Post #51 and I disagree about the size of the effect, not about the direction. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
Realistic expectations for strength while losing weight quickly Replied, post #15 · Nutrition & Training › Resistance training · 20 Aug 2025 · 16 likes Post #14 describes the usual case. This is about the unusual one. Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #82 · Compounds › Oral incretins · 14 Aug 2025 · 32 likes I had written a reply contradicting post #80 and deleted it. Here is what survived. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #53 · Compounds › Secretagogues & GH axis · 11 Aug 2025 · 0 likes Adding the measurement that post #52 says would settle it. A mass result for a short peptide is more discriminating than for a long one, because a single residue…
-
Immortal time bias in a claims-database study Replied, post #15 · Evidence › Study critique · 7 Aug 2025 · 20 likes Building on post #12 rather than restating it. Careful with the language on immortal time bias. "Not detected" and "not present" are different findings and the first is…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #34 · Compounds › Retatrutide · 3 Aug 2025 · 30 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. Mass and identity: a report on retatrutide should state the mass detected by LC-MS,…
-
A ten-fold dose error caught before injection — one year on Replied, post #76 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Which panel is worth repeating and which is worth ignoring Replied, post #73 · Clinical › Bloodwork · 31 Jul 2025 · 0 likes Panel has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #57 · Access › Insurance & coverage · 26 Jul 2025 · 20 likes The most useful reply I ever got about Reading a denial letter was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #5 · Compounds › Secretagogues & GH axis · 22 Jul 2025 · 0 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 15 likes Adding a reference point for Nausea profile of amylin analogues. Mine is a single case, collected without controls, and I am posting the method alongside it so it can…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #133 · Devices › Cold chain · 30 Jun 2025 · 0 likes I read post #129 twice before replying, because I had assumed the opposite. A temperature indicator that has tripped tells you a threshold was crossed. It does not tell…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #59 · Evidence › Journal club · 29 Jun 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #16 · Documentation › Doc review · 23 Jun 2025 · 0 likes This follows post #14 rather than contradicting it. I would call the community position on Promotion criteria likely rather than established, and I would be comfortable…
-
An emergency department visit, described afterwards Replied, post #24 · Safety › Adverse events · 25 May 2025 · 0 likes Speaking only to emergency department visit as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #80 · Sourcing › Independent verification · 11 May 2025 · 5 likes Worth separating two things that post #78 runs together. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
Albumin binding and how it produces a long half-life Replied, post #31 · Pharmacology › Pharmacokinetics · 1 May 2025 · 1 like Narrowing post #30, because the general version has more than one answer. The most useful reply I ever got about albumin binding was a request to state my units. It…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #40 · Compounds › Retatrutide · 20 Apr 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #25 · Compounds › Retatrutide · 20 Apr 2025 · 9 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #15 · Devices › Pens & autoinjectors · 9 Apr 2025 · 4 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Requesting a page: what makes a good request Replied, post #24 · Documentation › Wiki requests · 15 Mar 2025 · 0 likes Review cadence should be part of the proposal. A page about a fast-moving area needs a shorter cycle and somebody willing to honour it. Small point, but it is the one…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #15 · Evidence › Preprints · 4 Mar 2025 · 0 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
-
[2026 update] New subcategory: rationale and scope Replied, post #131 · Meta › Announcements · 8 Jan 2025 · 6 likes I would keep New subcategory and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
-
Transporting a vial for a weekend away Replied, post #21 · Practice › Storage & stability · 31 Oct 2024 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #61 · Analytics › Method validation · 28 Oct 2024 · 1 like Post #57 describes the usual case. This is about the unusual one. Precision and repeatability: within-run and between-run variability of the method. Acceptance…
-
Revisiting: A staff appointment, and what the role involves Replied, post #3 · Meta › Announcements · 7 Oct 2024 · 18 likes Reading this as a member rather than staff: the change is sensible and the explanation is better than the change. Publishing the failure mode that prompted it is what…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #124 · Nutrition & Training › Hydration & electrolytes · 30 Sep 2024 · 1 like Post #120 and I disagree about the size of the effect, not about the direction. Symptoms attributed to electrolytes here are non-specific and overlap with dehydration,…
-
When a red flag was a misunderstanding, and the retraction Replied, post #2 · Sourcing › Red flags · 12 Aug 2024 · 31 likes Second this, and I would have said it less carefully.
-
Guidelines revision: what changed and why Replied, post #123 · Meta › Announcements · 28 Jul 2024 · 4 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. Correct me on…
-
The mass-error checker and its intended scope Replied, post #160 · Data & Tools › Calculators · 28 Jul 2024 · 5 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #106 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes Small correction to my own earlier position on Retatrutide dose escalation. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
-
Spreadsheets: an appreciation Replied, post #28 · Lounge › Off topic · 10 Jun 2024 · 0 likes No disagreement from me. Posting only so the question does not look ignored.